BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 20.05% 41.93% 51.59% 42.58% 20.67% 9.55% 2.60% 0.91% 15.79% 04/07/2010
BIB Market Price 20.06% 42.12% 51.73% 42.51% 20.92% 9.51% 2.55% 0.91% 15.79% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/05/2025
  • NAV
    $81.15
  • NAV Change
    $-0.77 down caret
  • Market Price
    $81.16
  • Market Price Change
    $-0.71 down caret
  • Trading Volume (M)
    11,124
  • 30-Day Median Bid Ask Spread
    0.27%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 12/05/2025
  • NAV
    $81.15
  • NAV Change
    $-0.77 down caret
  • Market Price
    $81.16
  • Market Price Change
    $-0.71 down caret
  • Trading Volume (M)
    11,124
  • 30-Day Median Bid Ask Spread
    0.27%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2025

Holdings

as of 12/05/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.30% VRTX VERTEX PHARMACEUTICALS INC -- $4,559,354.80 10,010 2931034
5.22% AMGN AMGEN INC -- $4,487,823.56 13,604 2023607
4.88% GILD GILEAD SCIENCES INC -- $4,200,273.00 34,650 2369174
4.08% REGN REGENERON PHARMACEUTICALS -- $3,510,625.32 4,887 2730190
3.28% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,816,979.88 6,149 B00FWN1
2.57% AZN ASTRAZENECA PLC-SPONS ADR -- $2,208,778.74 24,493 2989044
2.37% INSM INSMED INC -- $2,039,796.00 9,999 2614487
1.52% ARGX ARGENX SE - ADR -- $1,303,992.99 1,447 BDVLM39
1.46% BIIB BIOGEN INC -- $1,257,315.50 6,935 2455965
1.22% UTHR UNITED THERAPEUTICS CORP -- $1,046,634.09 2,139 2430412
1.10% INCY INCYTE CORP -- $946,874.72 9,236 2471950
1.09% ILMN ILLUMINA INC -- $937,539.20 7,270 2613990
0.94% RPRX ROYALTY PHARMA PLC- CL A -- $812,359.31 20,447 BMVP7Y0
0.85% NBIX NEUROCRINE BIOSCIENCES INC -- $729,341.90 4,690 2623911
0.85% MEDP MEDPACE HOLDINGS INC -- $728,451.48 1,329 BDCBC61
0.82% RVMD REVOLUTION MEDICINES INC -- $704,176.88 8,842 BL71K91
0.79% ROIV ROIVANT SCIENCES LTD -- $677,331.00 32,300 BMW4NZ9
0.77% BBIO BRIDGEBIO PHARMA INC -- $665,779.24 9,041 BK1KWG8
0.75% SMMT SUMMIT THERAPEUTICS INC -- $643,340.16 35,136 BMTVQS7
0.73% SNY SANOFI-ADR -- $628,684.29 12,693 2964557
0.72% IONS IONIS PHARMACEUTICALS INC -- $615,703.84 7,538 BDJ0LS6
0.71% TEM TEMPUS AI INC -- $611,593.48 7,978 BSLSJJ0
0.71% MDGL MADRIGAL PHARMACEUTICALS INC -- $610,206.10 1,057 BD59BS7
0.70% VTRS VIATRIS INC -- $602,723.92 55,144 BMWS3X9
0.70% GH GUARDANT HEALTH INC -- $601,815.98 5,899 BFXC911
0.69% ASND ASCENDIS PHARMA A/S - ADR -- $589,818.24 2,871 BV9G6B8
0.66% EXEL EXELIXIS INC -- $564,791.52 12,732 2576941
0.60% ONC BEONE MEDICINES LTD-ADR -- $513,411.00 1,590 BYYWPW6
0.59% MRNA MODERNA INC -- $509,763.10 18,403 BGSXTS3
0.57% JAZZ JAZZ PHARMACEUTICALS PLC -- $486,699.60 2,868 B4Q5ZN4
0.56% BMRN BIOMARIN PHARMACEUTICAL INC -- $484,872.00 9,080 2437071
0.53% BNTX BIONTECH SE-ADR -- $457,957.50 4,758 BK6H543
0.51% RNA AVIDITY BIOSCIENCES INC -- $435,868.55 6,085 BMWHPY1
0.47% ARWR ARROWHEAD PHARMACEUTICALS IN -- $401,817.60 6,540 BYQBFJ8
0.43% CYTK CYTOKINETICS INC -- $371,692.20 5,660 BBBSBJ5
0.41% AXSM AXSOME THERAPEUTICS INC -- $352,308.42 2,361 BYZR4X4
0.41% HALO HALOZYME THERAPEUTICS INC -- $350,341.56 5,532 2975098
0.40% NUVL NUVALENT INC-A -- $345,678.40 3,154 BMVBZD3
0.40% MRUS MERUS NV -- $343,892.78 3,577 BZBY005
0.38% RYTM RHYTHM PHARMACEUTICALS INC -- $328,653.20 3,142 BF2YWG4
0.37% KRYS KRYSTAL BIOTECH INC -- $320,289.84 1,368 BD6JX35
0.34% PTCT PTC THERAPEUTICS INC -- $290,324.29 3,758 B17VCN9
0.33% PCVX VAXCYTE INC -- $285,433.68 6,141 BKPVGH6
0.31% PTGX PROTAGONIST THERAPEUTICS INC -- $263,750.30 2,942 BDCBCD8
0.30% COGT COGENT BIOSCIENCES INC -- $256,192.16 6,608 BLR6XK8
0.29% PRAX PRAXIS PRECISION MEDICINES I -- $246,998.04 996 BQ721R4
0.28% CRSP CRISPR THERAPEUTICS AG -- $244,242.72 4,294 BDHF4K6
0.27% ALKS ALKERMES PLC -- $230,492.16 7,808 B3P6D26
0.26% KYMR KYMERA THERAPEUTICS INC -- $225,308.84 3,382 BMPRZV5
0.26% ADMA ADMA BIOLOGICS INC -- $224,046.95 11,287 B9NSBM2
0.25% ACAD ACADIA PHARMACEUTICALS INC -- $218,971.20 7,980 2713317
0.24% CRNX CRINETICS PHARMACEUTICALS IN -- $207,868.18 4,454 BDD19F8
0.24% INDV INDIVIOR PLC -- $207,278.24 5,902 BP0BQQ5
0.24% AKRO AKERO THERAPEUTICS INC -- $206,417.20 3,784 BK7Y2V9
0.24% SRRK SCHOLAR ROCK HOLDING CORP -- $204,750.96 4,548 BFZQ0L8
0.22% IMVT IMMUNOVANT INC -- $188,292.96 8,244 BJRFSB7
0.22% -- NEWAMSTERDAM PHARMA CO NV -- $187,794.76 5,326 BP8JSP4
0.21% ACLX ARCELLX INC -- $182,455.88 2,623 BPCJ1Q2
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $180,933.90 14,855 BFNF1D6
0.21% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $176,841.60 5,668 BKX9VD3
0.20% GRAL GRAIL INC -- $172,271.88 1,706 BSLSSX7
0.20% LGND LIGAND PHARMACEUTICALS -- $171,374.49 927 2501578
0.19% APGE APOGEE THERAPEUTICS INC -- $167,468.50 2,182 BM9HHL5
0.19% VCYT VERACYTE INC -- $165,993.81 3,721 BFTWZY0
0.19% RARE ULTRAGENYX PHARMACEUTICAL IN -- $165,856.42 4,559 BJ62Z18
0.19% XENE XENON PHARMACEUTICALS INC -- $164,151.47 3,647 BRJ3GY4
0.19% TARS TARSUS PHARMACEUTICALS INC -- $163,212.92 1,996 BMH5RL1
0.19% MIRM MIRUM PHARMACEUTICALS INC -- $162,708.48 2,376 BJDX8Y8
0.18% CGON CG ONCOLOGY INC -- $156,183.10 3,607 BRBCSP4
0.18% IRON DISC MEDICINE INC -- $153,226.18 1,643 BMGJZJ8
0.17% IDYA IDEAYA BIOSCIENCES INC -- $148,645.28 4,144 BK0VHF6
0.17% TVTX TRAVERE THERAPEUTICS INC -- $147,525.00 4,215 BLFGJD5
0.17% FOLD AMICUS THERAPEUTICS INC -- $144,342.00 14,580 B19FQ48
0.16% APLS APELLIS PHARMACEUTICALS INC -- $141,165.62 5,974 BYTQ6X1
0.16% DNLI DENALI THERAPEUTICS INC -- $138,063.32 6,917 BD2B4V0
0.16% DYN DYNE THERAPEUTICS INC -- $136,443.84 6,728 BN15WD1
0.16% CNTA CENTESSA PHARMACEUTICALS-ADR -- $135,641.85 4,535 BLB0YQ9
0.16% VERA VERA THERAPEUTICS INC -- $135,508.20 3,018 BL55460
0.15% BEAM BEAM THERAPEUTICS INC -- $129,652.74 4,786 BK6L288
0.14% TERN TERNS PHARMACEUTICALS INC -- $121,344.88 4,133 BMDJ0C9
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $121,189.04 2,653 B72ZBG4
0.14% MLYS MINERALYS THERAPEUTICS INC -- $120,736.00 3,136 BP9N0G0
0.14% EWTX EDGEWISE THERAPEUTICS INC -- $117,548.97 4,983 BKY5JZ8
0.13% LEGN LEGEND BIOTECH CORP-ADR -- $112,013.66 3,982 BMX9K07
0.13% HRMY HARMONY BIOSCIENCES HOLDINGS -- $108,337.60 2,720 BKSGZN7
0.12% ADPT ADAPTIVE BIOTECHNOLOGIES -- $106,229.50 7,202 BJ5FZ74
0.12% OCUL OCULAR THERAPEUTIX INC -- $103,520.82 8,229 BNZB1X8
0.12% SRPT SAREPTA THERAPEUTICS INC -- $102,907.98 4,623 B8DPDT7
0.12% IBRX IMMUNITYBIO INC -- $102,383.61 44,709 BNSP0B8
0.11% AVDL AVADEL PHARMACEUTICALS -- $97,993.28 4,592 BDGMC59
0.11% GPCR STRUCTURE THERAPEUTICS INC -- $97,424.64 2,819 BQS9486
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $97,250.12 6,226 BFWLC09
0.11% TXG 10X GENOMICS INC-CLASS A -- $96,171.24 5,412 BKS3RS7
0.11% SYRE SPYRE THERAPEUTICS INC -- $95,566.65 2,857 BQBBDY8
0.11% RXRX RECURSION PHARMACEUTICALS-A -- $95,198.52 20,212 BM9FJ13
0.11% ZYME ZYMEWORKS INC -- $94,882.95 3,555 BPCQZY9
0.11% TWST TWIST BIOSCIENCE CORP -- $92,216.50 2,855 BGKG6G7
0.10% OLMA OLEMA PHARMACEUTICALS INC -- $88,323.66 3,246 BMZ4LN0
0.10% VCEL VERICEL CORP -- $86,444.78 2,386 BSBMN89
0.10% KNSA KINIKSA PHARMACEUTICALS INTE -- $85,673.52 2,056 BRXB0C0
0.10% ANIP ANI PHARMACEUTICALS INC -- $83,896.02 1,026 BCDWBX6
0.10% SNDX SYNDAX PHARMACEUTICALS INC -- $82,804.00 4,075 BN7Q7R7
0.10% MNKD MANNKIND CORP -- $82,433.84 14,513 BF081J4
0.09% ALVO ALVOTECH SA -- $80,977.88 14,804 BPNTJ34
0.09% HROW HARROW INC -- $80,062.50 1,750 BHNDW86
0.09% STOK STOKE THERAPEUTICS INC -- $80,015.04 2,592 BJQ05Z6
0.09% TRVI TREVI THERAPEUTICS INC -- $77,587.20 5,760 BJH9ZN0
0.09% AGIO AGIOS PHARMACEUTICALS INC -- $76,368.42 2,754 BCBVTX1
0.09% BCRX BIOCRYST PHARMACEUTICALS INC -- $75,368.70 9,930 2100362
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $73,449.32 1,894 BLCD809
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $71,385.90 1,490 BX7RSN3
0.08% ARDX ARDELYX INC -- $68,160.04 11,398 BN89V40
0.08% NRIX NURIX THERAPEUTICS INC -- $65,377.26 3,614 BMVLGP2
0.08% TSHA TAYSHA GENE THERAPIES INC -- $65,155.10 12,902 BNC1BX1
0.07% NVCR NOVOCURE LTD -- $64,037.68 5,288 BYSS4X4
0.07% GMAB GENMAB A/S -SP ADR -- $62,940.42 1,983 BBC9WC7
0.07% SANA SANA BIOTECHNOLOGY INC -- $62,770.68 12,236 BMFJJ97
0.07% RLAY RELAY THERAPEUTICS INC -- $62,622.72 8,154 BN2R582
0.07% INVA INNOVIVA INC -- $61,825.94 2,981 BDDXF67
0.07% INBX INHIBRX BIOSCIENCES INC -- $61,376.42 686 BNSP8K3
0.07% FTRE FORTREA HOLDINGS INC -- $61,146.56 4,294 BRXYZ57
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $61,089.81 2,801 BMFD115
0.07% DVAX DYNAVAX TECHNOLOGIES CORP -- $60,395.94 5,546 BRJZSK0
0.07% AMLX AMYLYX PHARMACEUTICALS INC -- $59,838.80 4,214 BPCK358
0.07% AMPH AMPHASTAR PHARMACEUTICALS IN -- $58,867.23 2,199 BNFWZS4
0.07% ANAB ANAPTYSBIO INC -- $58,763.75 1,325 BDRW1L7
0.07% XNCR XENCOR INC -- $58,370.20 3,374 BGCYWN8
0.07% EYPT EYEPOINT PHARMACEUTICALS INC -- $57,832.40 3,260 BMGS7L1
0.07% WVE WAVE LIFE SCIENCES LTD -- $56,377.23 7,527 BYZG9R0
0.06% QURE UNIQURE NV -- $55,351.35 2,595 BJFSR88
0.06% ORKA ORUKA THERAPEUTICS INC -- $54,617.64 1,771 BKVF0J2
0.06% TYRA TYRA BIOSCIENCES INC -- $54,201.50 2,521 BMVNDH9
0.06% SVRA SAVARA INC -- $53,144.00 8,176 BYXGN81
0.06% NVAX NOVAVAX INC -- $53,082.62 7,682 BJDQXG4
0.06% CSTL CASTLE BIOSCIENCES INC -- $52,975.44 1,371 BKLCWZ3
0.06% GRFS GRIFOLS SA-ADR -- $51,064.50 5,770 B8K7T65
0.06% PCRX PACIRA BIOSCIENCES INC -- $50,978.75 2,125 B3X26D8
0.06% ALMS ALUMIS INC -- $50,951.84 4,582 BPLQG36
0.06% RAPP RAPPORT THERAPEUTICS INC -- $50,946.50 1,727 BR3T9B6
0.06% GLUE MONTE ROSA THERAPEUTICS INC -- $50,854.61 2,921 BP7KZP7
0.06% PGEN PRECIGEN INC -- $50,734.80 14,093 BKM5C84
0.06% TNGX TANGO THERAPEUTICS INC -- $50,682.69 5,263 BP2P6L0
0.06% ORIC ORIC PHARMACEUTICALS INC -- $50,523.00 4,593 BKVDFF7
0.06% ABCL ABCELLERA BIOLOGICS INC -- $50,317.04 14,134 BL53SR3
0.06% URGN UROGEN PHARMA LTD -- $50,303.22 2,189 BZ7PJQ1
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $49,723.38 7,638 BLR7H87
0.06% KURA KURA ONCOLOGY INC -- $49,054.75 4,105 BYZD465
0.06% PHAT PHATHOM PHARMACEUTICALS INC -- $48,915.90 3,355 BJLKVS6
0.06% NTLA INTELLIA THERAPEUTICS INC -- $48,789.97 5,077 BYZM6C2
0.06% AVBP ARRIVENT BIOPHARMA INC -- $47,355.42 1,918 BMGTLY5
0.05% JANX JANUX THERAPEUTICS INC -- $46,921.42 2,842 BMFX8Y7
0.05% SPRY ARS PHARMACEUTICALS INC -- $46,412.82 4,674 BMCR7V2
0.05% MNMD MIND MEDICINE MINDMED INC -- $44,534.10 3,606 BPQYY97
0.05% ARVN ARVINAS INC -- $44,419.67 3,473 BDZ30Q0
0.05% TBPH THERAVANCE BIOPHARMA INC -- $44,186.10 2,382 BMNDK09
0.05% ZLAB ZAI LAB LTD-ADR -- $44,109.00 2,262 BD9GVY0
0.05% ERAS ERASCA INC -- $43,873.59 13,417 BNLYBF3
0.05% VIR VIR BIOTECHNOLOGY INC -- $42,705.00 6,570 BK4PZ38
0.05% KROS KEROS THERAPEUTICS INC -- $41,644.80 1,920 BM7V485
0.05% RIGL RIGEL PHARMACEUTICALS INC -- $41,533.08 849 BQD3J33
0.05% PSNL PERSONALIS INC -- $40,094.64 4,194 BJQ0608
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $40,076.14 9,067 BZ0QMB7
0.05% MESO MESOBLAST LTD- SPON ADR -- $39,903.71 2,233 BQS7491
0.05% GERN GERON CORP -- $39,531.87 30,177 2370381
0.05% REPL REPLIMUNE GROUP INC -- $39,172.12 3,692 BDDVW37
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $39,119.83 2,381 BD06CS0
0.04% DAWN DAY ONE BIOPHARMACEUTICALS I -- $38,364.48 4,844 BLB0YH0
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $37,711.08 963 BL95N25
0.04% IOVA IOVANCE BIOTHERAPEUTICS INC -- $37,655.20 17,116 BF0DMK7
0.04% CRMD CORMEDIX INC -- $37,287.36 3,531 BJ0LT31
0.04% AQST AQUESTIVE THERAPEUTICS INC -- $36,499.98 5,721 BYVQJ96
0.04% LENZ LENZ THERAPEUTICS INC -- $36,045.28 1,349 BQV0J03
0.04% ESPR ESPERION THERAPEUTICS INC -- $35,573.01 9,537 BBNBTD2
0.04% OMER OMEROS CORP -- $34,926.15 3,219 B4NB858
0.04% ATXS ASTRIA THERAPEUTICS INC -- $34,523.10 2,670 BMYRFN8
0.04% PACB PACIFIC BIOSCIENCES OF CALIF -- $33,954.73 14,207 B4N8MH9
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $32,913.25 3,805 BFYQFJ2
0.04% RGNX REGENXBIO INC -- $31,557.68 2,398 BZ0G875
0.04% CRVS CORVUS PHARMACEUTICALS INC -- $31,055.25 3,525 BYP80F1
0.04% PRME PRIME MEDICINE INC -- $30,933.54 8,271 BPBJFM7
0.03% CGEM CULLINAN THERAPEUTICS INC -- $29,577.87 2,793 BM90J52
0.03% PRTA PROTHENA CORP PLC -- $28,184.22 2,546 B91XRN2
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $26,733.36 7,682 B3MZ6K5
0.03% DSGN DESIGN THERAPEUTICS INC -- $26,310.61 2,693 BMFK3H6
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $25,322.80 6,844 BMCWKZ2
0.03% ABSI ABSCI CORP -- $25,321.34 7,073 BN94K69
0.03% CMPS COMPASS PATHWAYS PLC -- $25,247.16 4,338 BMC3HS7
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $24,064.60 17,189 BWFZX59
0.03% ANNX ANNEXON INC -- $23,935.12 5,192 BMVV9R5
0.03% LXEO LEXEO THERAPEUTICS INC -- $23,879.90 2,554 BQ6C357
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $23,636.30 2,209 BKLXFX5
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,133.76 2,656 BLFBZ32
0.03% LYEL LYELL IMMUNOPHARMA INC -- $22,977.50 910 BTNMG41
0.03% ALT ALTIMMUNE INC -- $21,877.00 4,175 BFY7DC4
0.02% GLPG GALAPAGOS NV-SPON ADR -- $21,418.02 678 B292NQ7
0.02% SLDB SOLID BIOSCIENCES INC -- $21,256.68 3,684 BQHN6C7
0.02% SIGA SIGA TECHNOLOGIES INC -- $20,999.40 3,387 2107437
0.02% EOLS EVOLUS INC -- $20,961.00 3,060 BDRJH21
0.02% HCM HUTCHMED CHINA-ADR -- $20,874.96 1,468 BYXV9H7
0.02% AURA AURA BIOSCIENCES INC -- $18,891.34 2,938 BP81R42
0.02% TRDA ENTRADA THERAPEUTICS INC -- $18,576.00 1,800 BP81RK8
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $17,872.80 4,062 BYTYP72
0.02% TECX TECTONIC THERAPEUTIC INC -- $17,629.20 885 BPBPCG8
0.02% NMRA NEUMORA THERAPEUTICS INC -- $17,005.20 7,660 BN4JN37
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $16,945.28 5,104 BDFKQ07
0.02% KYTX KYVERNA THERAPEUTICS INC -- $15,958.80 2,046 BSMLR16
0.02% AMRN AMARIN CORP PLC -ADR -- $15,762.62 953 BN72KB0
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $15,555.60 2,235 BL5B6Z1
0.02% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $15,440.88 2,184 BKDQKM6
0.02% VNDA VANDA PHARMACEUTICALS INC -- $15,059.66 2,794 B12W3P6
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $15,007.85 10,495 BFZNYB7
0.02% LRMR LARIMAR THERAPEUTICS INC -- $14,977.60 4,048 BMXNGZ6
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $14,775.20 1,012 B9L5200
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $14,703.30 9,486 BFMLGR4
0.02% NGNE NEUROGENE INC -- $13,709.28 676 BS2F741
0.02% ACIU AC IMMUNE SA -- $13,213.20 4,719 BZC0D70
0.01% PYXS PYXIS ONCOLOGY INC -- $12,377.26 2,933 BLBR8D5
0.01% TKNO ALPHA TEKNOVA INC -- $12,148.80 2,531 BP7L561
0.01% AVIR ATEA PHARMACEUTICALS INC -- $11,900.18 3,754 BLN9Z50
0.01% FHTX FOGHORN THERAPEUTICS INC -- $11,658.64 2,674 BMF7DT9
0.01% OABI OMNIAB INC -- $11,315.85 5,803 BN13S71
0.01% VYGR VOYAGER THERAPEUTICS INC -- $11,226.44 2,623 BY7RB53
0.01% EDIT EDITAS MEDICINE INC -- $10,292.26 4,253 BZ8FPH3
0.01% HUMA HUMACYTE INC -- $9,213.93 7,491 BMYTJP4
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $9,154.92 1,284 BKC9SX3
0.01% CCCC C4 THERAPEUTICS INC -- $8,989.89 3,367 BKX9NQ0
0.01% RNAC CARTESIAN THERAPEUTICS INC -- $8,469.28 1,231 BQB9HM8
0.01% PEPG PEPGEN INC -- $8,442.88 1,552 BMTX3D7
0.01% CDXS CODEXIS INC -- $7,812.27 4,269 B5LL2C2
0.01% MXCT MAXCYTE INC -- $7,413.21 5,043 BKMQF66
0.01% MRSN MERSANA THERAPEUTICS INC -- $6,554.90 236 BVPKH99
0.01% NKTX NKARTA INC -- $6,048.00 3,360 BK80YJ8
0.01% FATE FATE THERAPEUTICS INC -- $5,891.40 5,455 BCZS820
0.01% ALEC ALECTOR INC -- $5,841.36 4,788 BJ4LDC4
0.01% CLYM CLIMB BIO INC -- $5,514.32 3,206 BMW5LX6
-- MGNX MACROGENICS INC -- $4,096.30 2,990 BFDV8K0
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $3,884.16 1,156 BMF1LJ7
-- TVGN TEVOGEN BIO HOLDINGS INC -- $3,727.18 9,304 BPG5P75
-- ACRV ACRIVON THERAPEUTICS INC -- $3,526.56 1,488 BP2TPK4
-- PLRX PLIANT THERAPEUTICS INC -- $3,513.84 2,904 BMDWW66
-- -- SUTRO BIOPHARMA INC COMMON STOCK USD 0.001 -- $3,464.00 400 --
-- BMEA BIOMEA FUSION INC -- $3,434.30 2,815 BNKF6N0
-- TCRX TSCAN THERAPEUTICS INC -- $2,679.48 2,481 BNLYBJ7
-- QTTB Q32 BIO INC -- $1,912.32 576 BS2FKQ4
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,860.48 608 BT7KGT6
-- APLT APPLIED THERAPEUTICS INC -- $1,475.26 6,811 BJL38Z1
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
35.60% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 30,616,871 -- 5,335 --
33.41% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 28,740,261 -- 5,008 --
26.00% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 22,364,376 -- 3,897 --
16.57% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 14,255,353 -- 2,484 --
15.34% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 13,193,662 -- 2,299 --
4.22% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,632,705 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $26,791,384.66 26,791,385 --

Index

as of 9/30/2025

  • Total Number of Companies251
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.56 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.